BMC Palliative Care · 2019 · 32 citations · 15 references
MedicineGeriatric MedicineOncologyPalliative CarePalliative MedicineSurvival AnalysisCachexia ManagementPalliative Care For CancerPrognostic AssessmentSurvival PredictionKarnofsky Performance StatusPredictive Model AssessmentPredictive Model PerformanceWeight Loss MeasurementWeight Loss Prognosis
BACKGROUND: Early intervention against cachexia necessitates a predictive model. The aims of this study were to identify predictors of cachexia development and to create and evaluate accuracy of a predictive model based on these predictors. METHODS: . Clinical and demographic markers were evaluated as possible predictors with Cox analysis. A classification and regression tree analysis was used to create a model based on optimal combinations and cut-offs of significant predictors for cachexia development, and accuracy was evaluated with a calibration plot, Harrell's c-statistic and receiver operating characteristic curve analysis. RESULTS: Six-hundred-twenty-eight patients were included in the analysis. Median age was 65 years (IQR 17), 359(57%) were female and median Karnofsky performance status was 70(IQR 10). Median follow-up was 109 days (IQR 108), and 159 (25%) patients developed cachexia. Initial WL, cancer type, appetite and chronic obstructive pulmonary disease were significant predictors (p ≤ 0.04). A five-level model was created with each level carrying an increasing risk of cachexia development. For Risk-level 1-patients (WL < 3%, breast or hematologic cancer and no or little appetite loss), median time to cachexia development was not reached, while Risk-level 5-patients (WL 3-5%) had a median time to cachexia development of 51 days. Accuracy of cachexia predictions at 3 months was 76%. CONCLUSION: Important predictors of cachexia have been identified and used to construct a predictive model of cancer cachexia. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT01362816 .
15
Prognostic effect of weight loss prior tochemotherapy in cancer patients
William D. DeWys, Colin B. Begg, Philip T. Lavin et al. · The American Journal of Medicine · 1980 · 2.4K citations
Marked changes in body composition following neoadjuvant chemotherapy for oesophagogastric cancer
Sherif Awad, Benjamin Tan, Helen Cui et al. · Clinical Nutrition · 2011 · 273 citations